Central Nervous System

  • Charlotte Dai Kubicky
  • Linda W. Chan
  • Stuart Y. Tsuji
  • Jean L. Nakamura
  • Daphne Haas-Kogan
  • David A. Larson


This chapter will discuss malignant glioma, low-grade glioma, brainstem glioma, optic glioma, CNS lymphoma, ependymoma, choroid plexus tumor, meningioma, acoustic neuroma, craniopharyngioma, pituitary tumor, pineal tumor, medulloblastoma, primary spinal cord tumor, arteriovenous malformation, and trigeminal neuralgia. Brain metastases will be discussed in the palliative care chapter.


Trigeminal Neuralgia Spine Field Acoustic Neuroma Brainstem Glioma Choroid Plexus Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



  1. Abrey LE, Ben-Porat L, Panageas KS et al. Primary Central Nervous System Lymphoma: The Memorial Sloan-Kettering Cancer Center Prognostic Model. J Clin Oncol 2006; 36:5711-5715.CrossRefGoogle Scholar
  2. Bailey CC, Gnekow A, Wellek S, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 1995;25:166-178.Google Scholar
  3. Bull KS, Spoudeas HA, Yadegarfar G, et al. Reduction of health status 7 yrs after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET3 trial survivors on behalf of the CCLG (formerly UKCCSF). J Clin Oncol 2007;25:4239-4245.PubMedCrossRefGoogle Scholar
  4. Bauman GS, Gaspar LE, Fisher BJ, et al. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1994;29:835-839.PubMedCrossRefGoogle Scholar
  5. Bleehen NM, Stenning SP. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer 1991;64:769-774.Google Scholar
  6. Cairncross G, Berkey B, Shaw E, et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: intergroup radiation therapy oncology group trial 9402. J Clin Oncol 2006;24:2707-2714.PubMedCrossRefGoogle Scholar
  7. Cardinale R, Won M, Choucair A, et al. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Int J Radiat Oncol Biol Phys 2006;65:1422-1428.PubMedCrossRefGoogle Scholar
  8. Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. Radiology 1969; 93(6): 1351-1359.PubMedGoogle Scholar
  9. Chopra R, Kondziolka D, Niranjan A, et al. Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Biol Phys 2007;63:845-851.Google Scholar
  10. DeAngelis LM, Seiferheld W, Schold SC, et al. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 2002;20:4643-4648.PubMedCrossRefGoogle Scholar
  11. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725-1731.PubMedCrossRefGoogle Scholar
  12. Evans AE, Jenkin RD, Sposto R, et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 1990;72:572-582.Google Scholar
  13. Gajjar A, Chintagumpala M, Ashley D, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 2006;7:813-820.PubMedCrossRefGoogle Scholar
  14. Gavrilovic IT, Hormigo A, Yahalom J, et al. Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J Clin Oncol. 2006;24:4570-4574.PubMedCrossRefGoogle Scholar
  15. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children’s Cancer Group. J Clin Oncol 2005;23:7621-7631.PubMedCrossRefGoogle Scholar
  16. Goldsmith BJ, Wara WM, Wilson CB, et al. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994;80:195-201.Google Scholar
  17. Gripp S, Kambergs J, Wittkamp M, et al. Coverage of anterior fossa in whole-brain irradiation. Int J Radiat Oncol Biol Phys 2004;59:515-520.PubMedCrossRefGoogle Scholar
  18. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996;36:549-556.PubMedCrossRefGoogle Scholar
  19. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 2002;52:316-324.PubMedCrossRefGoogle Scholar
  20. Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for Glioblastoma in the Elderly. NEJM 2007; 356:1527-1535.PubMedCrossRefGoogle Scholar
  21. Koh E, Millar B, Menard C, et al. Fractionated stereotactic radiotherapy for acoustic neuroma. Single-institution experience at the Princess Margaret Hospital. Cancer 2007;109:1203-1210.Google Scholar
  22. Kondziolka D, Levy EI, Niranjan A, et al. Long-term outcomes after meningioma radiosurgery: physician and patient perspectives. J Neurosurg 1999;91:44-50.PubMedCrossRefGoogle Scholar
  23. Kuo PH, Kanak E, Abu-Alfa AK, et al. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 242; 647-649.Google Scholar
  24. Maruyama K, Kawahara N, Shin M, et al. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med 2005;352:146-153.PubMedCrossRefGoogle Scholar
  25. Merchant TE, Kun LE, Krasin MJ, et al. Multi-institutional prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys 2008;70:782-787.Google Scholar
  26. Nelson DF, Martz KL, Bonner H, et al. Non-Hodgkin’s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992;23:9-17.PubMedCrossRefGoogle Scholar
  27. Pomeroy SL. Treatment and prognosi1270s of medulloblastoma. Uptodate Online 17.3. Assessed Feb. 21, 2010.
  28. Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 2004;22:1583-1588.PubMedCrossRefGoogle Scholar
  29. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 2005;352:978-986.PubMedCrossRefGoogle Scholar
  30. Schultz C, Scott C, Sherman W, et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88-06. J Clin Oncol 1996;14:556-564.PubMedGoogle Scholar
  31. Shaw EG, Daumas-Duport C, Scheithauer BW, et al. Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 1989; 70:853-861.PubMedCrossRefGoogle Scholar
  32. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002;20:2267-2276.PubMedCrossRefGoogle Scholar
  33. Souhami L, Seiferheld W, Brachman D, et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 2004;60:853-860.PubMedCrossRefGoogle Scholar
  34. South M, Chiu JK, The BS, et al. Supine craniospinal irradiation using intrafractional junction shifts and field-in-field dose shaping: early experience at Methodist hospital. Int J Radiat Oncol Biol Phys 2008;71(2):477-483.PubMedCrossRefGoogle Scholar
  35. Stafford SL, Pollock BE, Foote RL, et al. Meningioma radiosurgery: tumor control, outcomes, and complications among 190 consecutive patients. Neurosurgery 2001;49(5):1029-1037.PubMedGoogle Scholar
  36. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC/NCIC trial. Lancet Oncol 2009;10:459-466.PubMedCrossRefGoogle Scholar
  37. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl J Med 2005;352:987-996.PubMedCrossRefGoogle Scholar
  38. Tait DM, Thornton-Jones H, Bloom HJ, et al. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 1990;26:464-469.PubMedGoogle Scholar
  39. Tarbell NJ, Smith AR, Adams J, et al. The challenge of conformal radiotherapy in the curative treatment of medulloblastoma. Int J Radiat Oncol Biol Phys 2000;46:265-266.PubMedCrossRefGoogle Scholar
  40. Taylor RE, Bailey CC, Robinson K, et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children’s Cancer Study Group PNET-3 study. J Clin Oncol 2003;21:1581-1591.PubMedCrossRefGoogle Scholar
  41. Thomas PR, Deutsch M, Kepner JL, et al. Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 2000;18:3004-3011.PubMedGoogle Scholar
  42. Van den Bent MJ, de Witte O, Hassel MB, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomized trial. Lancet 2005;366:985-990.PubMedCrossRefGoogle Scholar
  43. Van den Bent MJ, Carpentier AF, Brandes AA, et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas : a randomized European organisation for research and treatment of cancer phase III trial. J Clin Oncol 2006;24:2715-2722.PubMedCrossRefGoogle Scholar
  44. Walker MD, Alexander E, Jr., Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 1978;49:333-343.Google Scholar
  45. Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5:1725-1731.PubMedCrossRefGoogle Scholar
  46. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-1329.PubMedCrossRefGoogle Scholar
  47. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol 1999;17:832-845.PubMedGoogle Scholar

Further Reading

  1. Batchelor T, Loeffler S. Primary CNS lymphoma. J Clin Oncol 2006;24:1281-1288.Google Scholar
  2. Bauman GS, Fisher B, Schild S, et al. Meningioma, ependymoma, and other adult brain tumors. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 2nd ed: Elsevier; 2007. pp 539-566.Google Scholar
  3. Berger C, Thiesse P, Lellouch-Tubiana A, et al. Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery 1998;42:470-475.Google Scholar
  4. Broniscer A, Iacono L, Chintagumpala M, et al. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer 2005;103:133-139.Google Scholar
  5. Brown PD, Shaw EG. Low-grade gliomas. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 2nd ed: Elsevier; 2007. pp 493-514.Google Scholar
  6. Carter M, Nicholson J, Ross F, et al. Genetic abnormalities detected in ependymomas by comparative genomic hybridisation. Br J Cancer 2002; 86:929-939.Google Scholar
  7. Central Brain Tumor Registry of the United States. 2009 CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2005. Available at: Accessed on June 15, 2009.
  8. Cha S. Perfusion MR imaging of brain tumors. Top Magn Reson Imaging 2004;15:279-289.Google Scholar
  9. Cheuk AV, Chin LS, Petit JH, et al. Gamma knife surgery for trigeminal neuralgia: Outcome, imaging, and brainstem correlates. Int J Radiat Oncol Biol Phys 2004;60:537-541.Google Scholar
  10. Chung HT, Ma R, Toyota B, et al. Audiologic and treatment outcomes after linear accelerator-based stereotactic irradiation for acoustic neuroma. Int J Radiat Oncol Biol Phys 2004;59:1116-1121.Google Scholar
  11. Cowper SE. Nephrogenic systemic fibrosis: an overview. J Am Coll Radiol 2008;5:23-28.Google Scholar
  12. Fiveash JB, Nordal RA, Markert JM, et al. High-grade gliomas. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 2nd ed: Elsevier; 2007. pp 515-537.Google Scholar
  13. Freeman CR, Farmer J, Taylor RE. Central nervous system tumors in children. In: Perez CA, Brady LW, Halperin EC, et al., editors. Principles and practice of radiation oncology. 5th ed: Lippincott Williams and Wilkins; 2008. pp 1822-1849.Google Scholar
  14. Freire JE, Brady LW, Shields JA, et al. Eye and orbit. In: Perez CA, Brady LW, Halperin EC, et al., editors. Principles and practice of radiation oncology. 4th ed: Lippincott Williams and Wilkins; 2004. pp 876-896.Google Scholar
  15. Fulton DS, Urtasun RC, Scott-Brown I, et al. Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study. J Neurooncol 1992; 14:63-72.Google Scholar
  16. Gilbertson RJ, Bentley L, Hernan R, et al. ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res 2002;8:3054-3064.Google Scholar
  17. Goldsmith BJ. Meningeal tumors. In: Leibel SA, Phillips TL, editors. Textbook of radiation oncology. 2nd ed: Saunders; 2004. pp 497-514.Google Scholar
  18. Gupta N. Choroid plexus tumors in children. Neurosurg Clin N Am 2003;14:621-631.Google Scholar
  19. Gururangan S, Friedman HS. Recent advances in the treatment of pediatric brain tumors. Oncology (Huntingt) 2004;18:1649-1661; discussion 1662, 1665-1646, 1668.Google Scholar
  20. Huang D, Halberg FE. Pituitary tumors. In: Leibel SA, Phillips TL, editors. Textbook of radiation oncology. 2nd ed: Saunders; 2004. pp 533-548.Google Scholar
  21. Hukin J, Steinbok P, Lafay-Cousin L, et al. Intracystic bleomycin therapy for craniopharyngioma in children. Cancer 2007;109:2124-2131.Google Scholar
  22. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.Google Scholar
  23. Kondziolka D, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for the treatment of trigeminal neuralgia. Clin J Pain 2002;18:42-47.Google Scholar
  24. Lunsford LD, Niranjan A, Flickinger JC, et al. Radiosurgery of vestibular schwannomas: summary of experience in 829 cases. J Neurosurg 2005;102 Suppl:195-199.Google Scholar
  25. Maire JP, Caudry M, Darrouzet V, et al. Fractionated radiation therapy in the treatment of stage III and IV cerebello-pontine angle neurinomas: long-term results in 24 cases. Int J Radiat Oncol Biol Phys 1995;32:1137-1143.Google Scholar
  26. Maire JP, Caudry M, Guerin J, et al. Fractionated radiation therapy in the treatment of intracranial meningiomas: local control, functional efficacy, and tolerance in 91 patients. Int J Radiat Oncol Biol Phys 1995;33:315-321.Google Scholar
  27. Merchant TE. Central nervous system tumors in children. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 2nd ed: Elsevier; 2007. pp 1575-1591.Google Scholar
  28. Michalski JM. Spinal canal. In: Perez CA, Brady LW, Halperin EC, et al., editors. Principles and practice of radiation oncology. 5th ed: Lippincott Williams and Wilkins; 2008. pp 765-777.Google Scholar
  29. Mirimanoff R, Gorlia T, Mason W, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981- NCIC CE3 Phase III randomized trial. J Clin Oncol 2006;24:2563-2569.Google Scholar
  30. Nakamura M, Roser F, Michel J, et al. The natural history of incidental meningiomas. Neurosurgery 2003;52:62-71.Google Scholar
  31. Narayana A, Leibel SA. Primary and metastatic brain tumors in adults. In: Leibel SA, Phillips TL, editors. Textbook of radiation oncology. 2nd ed: Saunders; 2004. pp 463-497.Google Scholar
  32. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Central Nervous System Tumors. Available at: Accessed on June 25, 2009.
  33. Packer RJ, Gajjar A, Vezina G, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 2006;24:4202-4208.Google Scholar
  34. Roberge D, Shenouda G, Souhami L. Pituitary. In: Halperin EC, Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 5th ed: Lippincott Williams & Wilkins; 2008. pp 751-764.Google Scholar
  35. Shaw EG, Debinski W, Robbins ME. Central nervous system tumors overview. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 2nd ed: Elsevier; 2007. pp 459-491.Google Scholar
  36. Sheehan J, Pan HC, Stroila M, et al. Gamma knife surgery for trigeminal neuralgia: outcomes and prognostic factors. J Neurosurg 2005;102:434-441.Google Scholar
  37. Shrieve DC, Larson DA, Loeffler JS. Radiosurgery. In: Leibel SA, Phillips TL, editors. Textbook of radiation oncology. 2nd ed: Saunders; 2004. pp 549-564.Google Scholar
  38. Siker ML, Donahue BR, Vogelbaum MA, et al. Primary intracranial neoplasms. In: Halperin EC, Perez CA, Brady LW, editors. Principles and practice of radiation oncology. 5th ed: Lippincott Williams & Wilkins; 2008. pp 717-750.Google Scholar
  39. Silvani A, Eoli M, Salmaggi A, et al. Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: a single-institution study. J Neurooncol 2005;71:271-276.Google Scholar
  40. Varia MA, Ewend MG, Sharpless J, et al. Pituitary tumors. In: Gunderson LL, Tepper JE, editors. Clinical radiation oncology. 2nd ed: Elsevier; 2007. pp 567-589.Google Scholar
  41. Weil MD, Hass-Kogan DA, Wara WM. Pediatric central nervous system tumors. In: Leibel SA, Phillips TL, editors. Textbook of radiation oncology. 2nd ed: Saunders; 2004. pp 1199-1214.Google Scholar
  42. Wolff JE, Sajedi M, Coppes MJ, et al. Radiation therapy and survival in choroid plexus carcinoma. Lancet 1999;353:2126.Google Scholar

Copyright information

© Springer-Verlag New York 2010

Authors and Affiliations

  • Charlotte Dai Kubicky
    • 1
  • Linda W. Chan
    • 2
  • Stuart Y. Tsuji
    • 2
  • Jean L. Nakamura
    • 2
  • Daphne Haas-Kogan
    • 2
  • David A. Larson
    • 2
  1. 1.Radiation MedicineOregon Health and Science UniversityPortlandUSA
  2. 2.Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA

Personalised recommendations